Sriphoosanaphan S, Pantumongkol W, Kulpeng W, Charonpongsuntorn C, et al. Cost-utility analysis of atezolizumab combined with bevacizumab for unresectable hepatocellular carcinoma in Thailand. PLoS One 2024;19:e0300327.
PMID: 38512900